anethole has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ha, B; Jung, DB; Jung, JH; Kim, B; Kim, JH; Kim, JS; Kim, SH; Ko, H; Shim, B; Sohn, EJ; Won, G; Yoon, JJ; Yun, M | 1 |
| Ebrahimzadeh-Bideskan, A; Hadjzadeh, MA; Hosseinian, S; Khajavi-Rad, A; Salmani, H; Samadi-Noshahr, Z; Shafei, MN | 1 |
| Chen, A; Wang, H; Yin, Q; Zhang, B; Zhang, C | 1 |
3 other study(ies) available for anethole and transforming growth factor beta
| Article | Year |
|---|---|
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
Topics: Allylbenzene Derivatives; Anisoles; Antineoplastic Agents; Biomarkers; Cadherins; Epithelial-Mesenchymal Transition; Humans; Male; Matrix Metalloproteinase 9; Mesoderm; Molecular Structure; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Twist-Related Protein 1; Vimentin | 2014 |
trans-Anethole attenuated renal injury and reduced expressions of angiotensin II receptor (AT1R) and TGF-β in streptozotocin-induced diabetic rats.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta | 2021 |
Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-β-mediated fibrosis.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Choline; Diet; Liver; Liver Cirrhosis; Methionine; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Transforming Growth Factor beta | 2022 |